SNY Jun 2024 42.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:59PM EDT. Market open.
| Previous close | 7.30 |
| Open | 8.10 |
| Bid | 4.90 |
| Ask | 9.10 |
| Strike | 42.50 |
| Expiry date | 2024-06-21 |
| Day's range | 7.20 - 8.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
ZacksWhy Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR NewswireI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer. Dr. Dennis, who will join I-Mab effective June 17, 2024, will lead the Company's global clinical development efforts and serve as a member of I-Mab's Executive Leadership Team.
FortuneUsher and Apple CEO Tim Cook had a meeting. Now the Super Bowl performer is taking his ideas to Capitol Hill
Usher will join French pharma giant Sanofi in Washington, D.C., to discuss the importance of early screening for type 1 diabetes.
© 2024 Yahoo. All rights reserved.